CDCP1 and pancreatic neoplasm: CDCP1, also known as CD318, gp140, SIMA135, and Trask, is a single-pass transmembrane glycoprotein that is overexpressed in several malignancies, including pancreatic cancer, where it correlates with worse prognosis (5).